Research
Research Field
Prof. Yu is interested in various fields related to personalized drug therapy, early phase clinical trials, pharmacokinetic-pharmacodynamic (PK-PD) modeling and clinical trial simulation, and also digital therapeuticsHe is conducting many clinical research projects every year, spanning various kinds of trials such as first-time-in-human studies, PK-PD studies, drug-drug interaction studies, new formulation PK evaluations, clinical pharmacogenomic studies, PK-PD support in phase 2 or 3 trials, and also is giving many consultations regarding clinical pharmacotherapy and new drug development.
Keyword
Personalized Drug Therapy, Clinical Pharmacokinetics (PK) and Pharmacodynamics (PD), PK-PD modeling and Simulation, Therapeutic Drug Monitoring (TDM), Digital Therapeutics (DTx)Intensive Major
Education
- ㅡSeoul National University College of Medicine, Seoul, Korea : M.D.
- ㅡ Seoul National University Graduate School, Seoul, Korea : Ph.D. in Clinical Pharmacology
- ㅡYonsei Graduate School of Business, Seoul, Korea : M.B.A. in International Business
Career
- Head Professor and Chair, Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital
- Professor, Department of Biomedical Sciences, Seoul National University Graduate School of Medicine
Publication
- Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. Br J Clin Pharmaco. 2021
- Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial. BMJ 2021
- Population pharmacokinetic study of prophylactic fluconazole in preterm infants for prevention of invasive candidiasis. Antimicrobial Agents and Chemotherapy. 2019
- Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients. Bone Marrow Transplantation. 2019
- Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials. Pharmaceutical Research. 2018
- Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers. Drug Design, Development and Therapy. 2018